IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding
Buckley, G.M., Ceska, T.A., Fraser, J.L., Gowers, L., Groom, C.R., Higueruelo, A.P., Jenkins, K., Mack, S.R., Morgan, T., Parry, D.M., Pitt, W.R., Rausch, O., Richard, M.D., Sabin, V.(2008) Bioorg Med Chem Lett 18: 3291-3295
- PubMed: 18482836 
- DOI: https://doi.org/10.1016/j.bmcl.2008.04.039
- Primary Citation of Related Structures:  
3CGF, 3CGO - PubMed Abstract: 
A potent IRAK-4 inhibitor was identified through routine project cross screening. The binding mode was inferred using a combination of in silico docking into an IRAK-4 homology model, surrogate crystal structure analysis and chemical analogue SAR.
Organizational Affiliation: 
UCB, Granta Park, Great Abington, Cambridge CB21 6GS, UK.